Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-1-68038-086-6
- Number of Report Pages: 170
- Format: PDF, Horizon Databook
- Historical Range: 2018 - 2023
- Forecast Period: 2024 - 2030
- Industry: Healthcare
Market Segmentation
- Nuclear Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Nuclear Medicine Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Nuclear Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostic Centers
- Others
- Nuclear Medicine Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- North America Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- North America Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- U.S.
- U.S. Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- U.S. Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- U.S. Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- U.S. Nuclear Medicine Market, By Product
- Canada
- Canada Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Canada Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Canada Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Canada Nuclear Medicine Market, By Product
- Mexico
- Mexico Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Mexico Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Mexico Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Mexico Nuclear Medicine Market, By Product
- North America Nuclear Medicine Market, By Product
- Europe
- Europe Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Europe Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Europe Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Germany
- Germany Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Germany Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Germany Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Germany Nuclear Medicine Market, By Product
- U.K.
- U.K. Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- U.K. Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- U.K. Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- U.K. Nuclear Medicine Market, By Product
- France
- France Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- France Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- France Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- France Nuclear Medicine Market, By Product
- Italy
- Italy Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Italy Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Italy Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Italy Nuclear Medicine Market, By Product
- Spain
- Spain Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Spain Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Spain Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Spain Nuclear Medicine Market, By Product
- Denmark
- Denmark Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Denmark Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Denmark Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Denmark Nuclear Medicine Market, By Product
- Sweden
- Denmark Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Sweden Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Sweden Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Denmark Nuclear Medicine Market, By Product
- Norway
- Norway Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Norway Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Norway Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Norway Nuclear Medicine Market, By Product
- Europe Nuclear Medicine Market, By Product
- Asia Pacific
- Asia Pacific Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Asia Pacific Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Asia Pacific Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- China
- China Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- China Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- China Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- China Nuclear Medicine Market, By Product
- Japan
- Japan Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Japan Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Japan Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Japan Nuclear Medicine Market, By Product
- India
- India Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- India Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- India Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- India Nuclear Medicine Market, By Product
- South Korea
- South Korea Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- South Korea Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- South Korea Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- South Korea Nuclear Medicine Market, By Product
- Australia
- Australia Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Australia Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Australia Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Australia Nuclear Medicine Market, By Product
- Thailand
- Thailand Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Thailand Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Thailand Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Thailand Nuclear Medicine Market, By Product
- Asia Pacific Nuclear Medicine Market, By Product
- Latin America
- Latin America Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Latin America Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Latin America Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Brazil
- Brazil Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Brazil Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Brazil Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Brazil Nuclear Medicine Market, By Product
- Argentina
- Argentina Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Argentina Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Argentina Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Argentina Nuclear Medicine Market, By Product
- Latin America Nuclear Medicine Market, By Product
- Middle East and Africa (MEA)
- Middle East and Africa Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Middle East and Africa Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Middle East and Africa Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- South Africa
- South Africa Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- South Africa Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- South Africa Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- South Africa Nuclear Medicine Market, By Product
- Saudi Arabia
- Saudi Arabia Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Saudi Arabia Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Saudi Arabia Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Saudi Arabia Nuclear Medicine Market, By Product
- Kuwait
- Kuwait Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- Kuwait Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Kuwait Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Kuwait Nuclear Medicine Market, By Product
- UAE
- UAE Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Alpha Emitters
- Diagnostics
- UAE Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- UAE Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- UAE Nuclear Medicine Market, By Product
- Middle East and Africa Nuclear Medicine Market, By Product
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
